Verbal ability impairment in juvenile systemic lupus erythematosus
Autor(a) principal: | |
---|---|
Data de Publicação: | 2010 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Repositório Institucional da UNIFESP |
Texto Completo: | http://dx.doi.org/10.1590/S0482-50042010000400003 http://repositorio.unifesp.br/handle/11600/45408 |
Resumo: | Introduction/Objective: Evaluate the frequency of verbal ability impairment and associated factors in patients with juvenile systemic lupus erythematosus (JSLE). Patients and Methods: Cross sectional study of 36 children and adolescents with JSLE of a group of 57 patients at the Clinic of Rheumatology, Department of Pediatrics and Medical Clinic of Santa Casa de Misericordia de Sao Paulo. At the time of diagnosis and study, we analyzed the following epidemiological features: clinical, socioeconomic, and educational level. Patients underwent cognitive and laboratory tests and we assessed disease activity (SLEDAI), cumulative damage (SLICC-DI), and treatment with corticosteroids. The patients underwent cognitive tests (Wechsler Intelligence Scales: WISC III and Waiss III), and the results were evaluated according to epidemiological, clinical, laboratory and treatment features. Results: The mean age at diagnosis was 11.2 +/- 2 years and at the time of the study the mean age was 15.4 +/- 4.7 years. There was predominance of women (89%) and of socioeconomic class C patients (61.1%). The cognitive impairment found in these patients was frequent (58.3%), affecting more often the verbal ability. We found association of verbal ability impairment with low socioeconomic status and cumulative damage (P < 0.05), but not with disease activity, presence of autoantibodies, and dose of corticosteroids (P > 0.05). Conclusions: Change in verbal ability is frequent in JSLE and is associated with socioeconomic status and cumulative damage, and should be suspected and investigated, particularly in pediatric patients to avoid quality of life impairment in adulthood. As it is not related with disease activity or presence of autoantibodies, it should always be assessed in the presence or absence of these factors. Likewise, the doses of corticosteroids should be independently evaluated. |
id |
UFSP_a9896e64f293267b0519313169db1e58 |
---|---|
oai_identifier_str |
oai:repositorio.unifesp.br/:11600/45408 |
network_acronym_str |
UFSP |
network_name_str |
Repositório Institucional da UNIFESP |
repository_id_str |
3465 |
spelling |
Verbal ability impairment in juvenile systemic lupus erythematosusComprometimento da habilidade verbal no lúpus eritematoso sistêmico juvenilsystemic lupus erythematosuscognitionchildadolescentcognitive testsIntroduction/Objective: Evaluate the frequency of verbal ability impairment and associated factors in patients with juvenile systemic lupus erythematosus (JSLE). Patients and Methods: Cross sectional study of 36 children and adolescents with JSLE of a group of 57 patients at the Clinic of Rheumatology, Department of Pediatrics and Medical Clinic of Santa Casa de Misericordia de Sao Paulo. At the time of diagnosis and study, we analyzed the following epidemiological features: clinical, socioeconomic, and educational level. Patients underwent cognitive and laboratory tests and we assessed disease activity (SLEDAI), cumulative damage (SLICC-DI), and treatment with corticosteroids. The patients underwent cognitive tests (Wechsler Intelligence Scales: WISC III and Waiss III), and the results were evaluated according to epidemiological, clinical, laboratory and treatment features. Results: The mean age at diagnosis was 11.2 +/- 2 years and at the time of the study the mean age was 15.4 +/- 4.7 years. There was predominance of women (89%) and of socioeconomic class C patients (61.1%). The cognitive impairment found in these patients was frequent (58.3%), affecting more often the verbal ability. We found association of verbal ability impairment with low socioeconomic status and cumulative damage (P < 0.05), but not with disease activity, presence of autoantibodies, and dose of corticosteroids (P > 0.05). Conclusions: Change in verbal ability is frequent in JSLE and is associated with socioeconomic status and cumulative damage, and should be suspected and investigated, particularly in pediatric patients to avoid quality of life impairment in adulthood. As it is not related with disease activity or presence of autoantibodies, it should always be assessed in the presence or absence of these factors. Likewise, the doses of corticosteroids should be independently evaluated.Irmandade Santa Casa Misericordia Sao Paulo, Dept Pediat, Disciplina Reumatol, Sao Paulo, BrazilWeb of ScienceElsevier B.V.Universidade Federal de São Paulo (UNIFESP)Santos, Maria Carolina dosOkuda, Eunice MitikoRonchezel, Marcos Vinicius [UNIFESP]Leon, Elaine PiresTrindade, Vilma dos Santos [UNIFESP]Bastos, Wanda AlvesSacchetti, Silvana Brasilia2018-06-18T11:48:18Z2018-06-18T11:48:18Z2010-07-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion362-374application/pdfapplication/pdfhttp://dx.doi.org/10.1590/S0482-50042010000400003Revista Brasileira De Reumatologia. New York: Elsevier Science Inc, v. 50, n. 4, p. 362-374, 2010.10.1590/S0482-50042010000400003S0482-50042010000400003-pt.pdfS0482-50042010000400003-en.pdf0482-5004S0482-50042010000400003http://repositorio.unifesp.br/handle/11600/45408WOS:000208389400003porRevista Brasileira De Reumatologiainfo:eu-repo/semantics/openAccesshttp://www.elsevier.com/about/open-access/open-access-policies/article-posting-policyreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-08-10T01:41:14Zoai:repositorio.unifesp.br/:11600/45408Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-08-10T01:41:14Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false |
dc.title.none.fl_str_mv |
Verbal ability impairment in juvenile systemic lupus erythematosus Comprometimento da habilidade verbal no lúpus eritematoso sistêmico juvenil |
title |
Verbal ability impairment in juvenile systemic lupus erythematosus |
spellingShingle |
Verbal ability impairment in juvenile systemic lupus erythematosus Santos, Maria Carolina dos systemic lupus erythematosus cognition child adolescent cognitive tests |
title_short |
Verbal ability impairment in juvenile systemic lupus erythematosus |
title_full |
Verbal ability impairment in juvenile systemic lupus erythematosus |
title_fullStr |
Verbal ability impairment in juvenile systemic lupus erythematosus |
title_full_unstemmed |
Verbal ability impairment in juvenile systemic lupus erythematosus |
title_sort |
Verbal ability impairment in juvenile systemic lupus erythematosus |
author |
Santos, Maria Carolina dos |
author_facet |
Santos, Maria Carolina dos Okuda, Eunice Mitiko Ronchezel, Marcos Vinicius [UNIFESP] Leon, Elaine Pires Trindade, Vilma dos Santos [UNIFESP] Bastos, Wanda Alves Sacchetti, Silvana Brasilia |
author_role |
author |
author2 |
Okuda, Eunice Mitiko Ronchezel, Marcos Vinicius [UNIFESP] Leon, Elaine Pires Trindade, Vilma dos Santos [UNIFESP] Bastos, Wanda Alves Sacchetti, Silvana Brasilia |
author2_role |
author author author author author author |
dc.contributor.none.fl_str_mv |
Universidade Federal de São Paulo (UNIFESP) |
dc.contributor.author.fl_str_mv |
Santos, Maria Carolina dos Okuda, Eunice Mitiko Ronchezel, Marcos Vinicius [UNIFESP] Leon, Elaine Pires Trindade, Vilma dos Santos [UNIFESP] Bastos, Wanda Alves Sacchetti, Silvana Brasilia |
dc.subject.por.fl_str_mv |
systemic lupus erythematosus cognition child adolescent cognitive tests |
topic |
systemic lupus erythematosus cognition child adolescent cognitive tests |
description |
Introduction/Objective: Evaluate the frequency of verbal ability impairment and associated factors in patients with juvenile systemic lupus erythematosus (JSLE). Patients and Methods: Cross sectional study of 36 children and adolescents with JSLE of a group of 57 patients at the Clinic of Rheumatology, Department of Pediatrics and Medical Clinic of Santa Casa de Misericordia de Sao Paulo. At the time of diagnosis and study, we analyzed the following epidemiological features: clinical, socioeconomic, and educational level. Patients underwent cognitive and laboratory tests and we assessed disease activity (SLEDAI), cumulative damage (SLICC-DI), and treatment with corticosteroids. The patients underwent cognitive tests (Wechsler Intelligence Scales: WISC III and Waiss III), and the results were evaluated according to epidemiological, clinical, laboratory and treatment features. Results: The mean age at diagnosis was 11.2 +/- 2 years and at the time of the study the mean age was 15.4 +/- 4.7 years. There was predominance of women (89%) and of socioeconomic class C patients (61.1%). The cognitive impairment found in these patients was frequent (58.3%), affecting more often the verbal ability. We found association of verbal ability impairment with low socioeconomic status and cumulative damage (P < 0.05), but not with disease activity, presence of autoantibodies, and dose of corticosteroids (P > 0.05). Conclusions: Change in verbal ability is frequent in JSLE and is associated with socioeconomic status and cumulative damage, and should be suspected and investigated, particularly in pediatric patients to avoid quality of life impairment in adulthood. As it is not related with disease activity or presence of autoantibodies, it should always be assessed in the presence or absence of these factors. Likewise, the doses of corticosteroids should be independently evaluated. |
publishDate |
2010 |
dc.date.none.fl_str_mv |
2010-07-01 2018-06-18T11:48:18Z 2018-06-18T11:48:18Z |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.1590/S0482-50042010000400003 Revista Brasileira De Reumatologia. New York: Elsevier Science Inc, v. 50, n. 4, p. 362-374, 2010. 10.1590/S0482-50042010000400003 S0482-50042010000400003-pt.pdf S0482-50042010000400003-en.pdf 0482-5004 S0482-50042010000400003 http://repositorio.unifesp.br/handle/11600/45408 WOS:000208389400003 |
url |
http://dx.doi.org/10.1590/S0482-50042010000400003 http://repositorio.unifesp.br/handle/11600/45408 |
identifier_str_mv |
Revista Brasileira De Reumatologia. New York: Elsevier Science Inc, v. 50, n. 4, p. 362-374, 2010. 10.1590/S0482-50042010000400003 S0482-50042010000400003-pt.pdf S0482-50042010000400003-en.pdf 0482-5004 S0482-50042010000400003 WOS:000208389400003 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
Revista Brasileira De Reumatologia |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess http://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
http://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy |
dc.format.none.fl_str_mv |
362-374 application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Elsevier B.V. |
publisher.none.fl_str_mv |
Elsevier B.V. |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UNIFESP instname:Universidade Federal de São Paulo (UNIFESP) instacron:UNIFESP |
instname_str |
Universidade Federal de São Paulo (UNIFESP) |
instacron_str |
UNIFESP |
institution |
UNIFESP |
reponame_str |
Repositório Institucional da UNIFESP |
collection |
Repositório Institucional da UNIFESP |
repository.name.fl_str_mv |
Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP) |
repository.mail.fl_str_mv |
biblioteca.csp@unifesp.br |
_version_ |
1814268281225216000 |